Vertex Pharmaceuticals Inc. buy Guggenheim
Start price
06.08.25
/
50%
€329.95
Target price
06.08.26
€471.96
Performance (%)
13.96%
Price
14:01
€376.00
Summary
This prediction is currently active. The BUY prediction by Guggenheim currently has a performance of 13.96%. This prediction currently runs until 06.08.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 1.141% | 1.141% |
| iShares Core DAX® | 4.244% | 2.864% |
| iShares Nasdaq 100 | 4.890% | 2.814% |
| iShares Nikkei 225® | 9.397% | 7.826% |
| iShares S&P 500 | 3.528% | 1.950% |
Comments by Guggenheim for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at Guggenheim from $558.00 to $546.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Guggenheim for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€453.20
02.08.24
02.08.24
€511.18
02.08.25
02.08.25
-11.90%
03.08.25
03.08.25
